Classic peptide drug has often been constrained by reduced bioavailability and enzymatic durability. However, emerging technologies are promoting a true transformation in peptide design. New next-generation peptides, https://nextgen-peptides611493.bloggers-hub.com/61677774/redefining-drug-research-with-advanced-short-proteins